LAURUSLABS

Laurus Labs Share Price

 

 

Invest in Laurus Labs with 3.29X leverage

Invest with MTF
Laurus Labs live price: ₹1045.9. It opened at ₹1,037 vs previous close ₹1,031; intraday high/low: ₹1,058/₹1,034. The 50 & 200 DMA stand at ₹1,022.81/₹905.89.

Laurus Labs Performance

  • Low
  • ₹1,034
  • High
  • ₹1,058
  • 52 Week Low
  • ₹518
  • 52 Week High
  • ₹1,141
  • Open Price₹1,037
  • Previous Close₹1,031
  • Volume938,473
  • 50 DMA₹1,022.81
  • 100 DMA₹991.20
  • 200 DMA₹905.89

Investment Returns

  • Over 1 Month + 6.69%
  • Over 3 Month + 3.2%
  • Over 6 Month + 19.65%
  • Over 1 Year + 91.73%

Smart Investing Starts Here Start SIP with Laurus Labs for Steady Growth!

Invest Now

Laurus Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 67
  • PEG Ratio
  • 0.2
  • Market Cap Cr
  • 56,464
  • P/B Ratio
  • 11.2
  • Average True Range
  • 33.86
  • EPS
  • 15.62
  • Dividend Yield
  • 0.2
  • MACD Signal
  • 7.8
  • RSI
  • 53.52
  • MFI
  • 54.78

Laurus Labs Financials

Laurus Labs Technicals

EMA & SMA

Current Price
₹1,045.90
+ 15.3 (1.48%)
pointer
  • Bearish Moving Average 3
  • Bullish Moving Average 13
  • 20 Day
  • ₹1,033.58
  • 50 Day
  • ₹1,022.81
  • 100 Day
  • ₹991.20
  • 200 Day
  • ₹905.89

Resistance and Support

1045.77 Pivot Speed
  • R3 1,081.83
  • R2 1,069.77
  • R1 1,057.83
  • S1 1,033.83
  • S2 1,021.77
  • S3 1,009.83

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Laurus Labs Ltd. is a leading pharmaceutical company specializing in the development and manufacture of Active Pharmaceutical Ingredients (APIs), focusing on anti-retrovirals, oncology, and cardiovascular treatments. It also provides contract development and manufacturing (CDMO) services globally.

Laurus Labs has an operating revenue of Rs. 6,721.63 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 9% is okay, ROE of 8% is fair but needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 18% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 9% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 77 which is a FAIR score but needs to improve its earnings, a RS Rating of 91 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 58 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Laurus Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-23 Quarterly Results
2025-10-23 Quarterly Results & Interim Dividend
2025-07-25 Quarterly Results
2025-04-24 Audited Results & Interim Dividend
2025-01-24 Quarterly Results
Date Purpose Remarks
2025-10-31 INTERIM Rs.0.80 per share(40%)Interim Dividend
2025-05-09 INTERIM Rs.0.80 per share(40%)Second Interim Dividend
2024-11-06 INTERIM Rs.0.40 per share(20%)Interim Dividend
2024-05-08 INTERIM Rs.0.40 per share(20%)Interim Dividend
2023-11-02 INTERIM Rs.0.40 per share(20%)Interim Dividend
View Laurus Labs Dividend History Arrow

Laurus Labs F&O

Laurus Labs Shareholding Pattern

27.49%
9.49%
1.52%
26.52%
0%
22.64%
12.34%

Laurus Labs FAQs

Laurus Labs share price is ₹1,045 As on 05 March, 2026 | 18:29

The Market Cap of Laurus Labs is ₹56463.6 Cr As on 05 March, 2026 | 18:29

The P/E ratio of Laurus Labs is 67 As on 05 March, 2026 | 18:29

The PB ratio of Laurus Labs is 11.2 As on 05 March, 2026 | 18:29

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23